Prolonged skin allograft survival by rM180 amelogenin in a murine skin transplantation model
These results may suggest that amelogenin can be a safe immunosuppressant or therapeutic agent against autoimmune diseases without inducing unfavorable side effects.
Authors
- Takaharu Taketomi (ORCID: https://orcid.org/0000-0002-6002-5512)
- Mwannes Ahmad
- Takao Fukuda (ORCID: https://orcid.org/0000-0003-0430-1874)
- Miyu Shida
- Yuki Nishimura (ORCID: https://orcid.org/0000-0002-4172-0472)
- Takanori Shinjo (ORCID: https://orcid.org/0000-0002-8269-2826)
- Terukazu Sanui (ORCID: https://orcid.org/0000-0002-5249-9574)
- Ziyu Wang (ORCID: https://orcid.org/0000-0002-8615-1816)
- Karen Yotsumoto
- Jinfeng Li
- Fusanori Nishimura (ORCID: https://orcid.org/0000-0003-1572-2180)
- Chikako Hayashi (ORCID: https://orcid.org/0009-0008-2258-7478)
- Meng Xiao
Institutions
- Kyushu University (JP)
- Kurume University Medical Center (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.3389/fimmu.2025.1663437
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00